Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;6(3):543-51.
doi: 10.2215/CJN.04690510. Epub 2010 Nov 29.

Blood pressure control and left ventricular mass in children with chronic kidney disease

Affiliations

Blood pressure control and left ventricular mass in children with chronic kidney disease

Manish D Sinha et al. Clin J Am Soc Nephrol. 2011 Mar.

Abstract

Background and objectives: Heart disease is a major cause of death in young adults with chronic kidney disease (CKD). Left ventricular hypertrophy (LVH) is common and is associated with hypertension. The aims of this study were to evaluate whether there is a relationship between LVH and BP in children with CKD and whether current targets for BP control are appropriate.

Design, setting, participants, & measurements: In this single-center cross-sectional study, 49 nonhypertensive children, (12.6 ± 3.0 years, mean GFR 26.1 ± 12.9 ml/min per 1.73 m²) underwent echocardiographic evaluation and clinic and 24-hour ambulatory BP monitoring. LVH was defined using age-specific reference intervals for left ventricular mass index (LVMI). Biochemical data and clinic BP for 18 months preceding study entry were also analyzed.

Results: The mean LVMI was 37.8 ± 9.1 g/m²·⁷, with 24 children (49%) exhibiting LVH. Clinic BP values were stable over the 18 months preceding echocardiography. Patients with LVH had consistently higher BP values than those without, although none were overtly hypertensive (> 95th percentile). Multiple linear regression demonstrated a strong relationship between systolic BP and LVMI. Clinic systolic BP showed a stronger relationship than ambulatory measures. Of the confounders evaluated, only elemental calcium intake yielded a consistent, positive relationship with LVMI.

Conclusions: LVMI was associated with systolic BP in the absence of overt hypertension, suggesting that current targets for BP control should be re-evaluated. The association of LVMI with elemental calcium intake questions the appropriateness of calcium-based phosphate binders in this population.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(a) Relationship of clinic SBP z-score with indexed LVM in all patients. (b) Relationship of clinic SBP z-score with LVM for height-specific z-scores (20) in all patients.
Figure 2.
Figure 2.
Clinic SBP z-scores in children with CKD stage 3 to 5 with and without LVH. LVH was defined using age-specific reference intervals for normal children (19). Interrupted lines at the 90th and 95th percentile denote the clinical definition of prehypertension and hypertension, respectively (15). Data are shown as mean ± SEM. (b) Clinic DBP z-scores in CKD stage 3 to 5 patients with and without LVH. LVH was defined using age-specific reference intervals for normal children (19). Interrupted lines at the 90th and 95th percentile denote the clinical definition of prehypertension and hypertension, respectively (15). Data are shown as mean ± SEM.

References

    1. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH: Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25: 1056–1062, 1995 - PubMed
    1. Turnbull F; Blood Pressure Lowering Treatment Trialists' Collaboration: Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet 362: 1527–1535, 2003 - PubMed
    1. McDonald SP, Craig JC: Long-term survival of children with end-stage renal disease. N Engl J Med 350: 2654–2662, 2004 - PubMed
    1. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT, Jr: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32: 853–906, 1998 - PubMed
    1. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134: 629–636, 2001 - PubMed

Publication types

MeSH terms